Repare Interest Income from 2010 to 2026

RPTX Stock

USD 2.65 0.00 0.00%

Repare Therapeutics Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

1.2 M

Current Value

2.2 M

Quarterly Volatility

1.3 M

Covid

Interest Hikes

Check Repare Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repare Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 2.6 M, Interest Income of 12.5 M or Depreciation And Amortization of 1.3 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0 or PTB Ratio of 0.23. Repare financial statements analysis is a perfect complement when working with Repare Therapeutics Valuation or Volatility modules.

Build AI portfolio with Repare Stock

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

The evolution of Interest Income for Repare Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Repare Therapeutics compares to historical norms and industry peers.

Latest Repare Therapeutics' Interest Income Growth Pattern

Below is the plot of the Interest Income of Repare Therapeutics over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Repare Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Repare Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Repare Interest Income Regression Statistics

	Arithmetic Mean	4,075,105
	Geometric Mean	2,006,587
	Coefficient Of Variation	115.80
	Mean Deviation	3,917,913
	Median	1,762,000
	Standard Deviation	4,719,037
	Sample Variance	22.3T
	Range	12.9M
	R-Value	0.72
	Mean Square Error	11.6T
	R-Squared	0.51
	Significance	0
	Slope	669,673
	Total Sum of Squares	356.3T

Repare Interest Income History

	2026	12.5 M
	2025	11.9 M
	2024	10.4 M
	2023	13.2 M
	2022	5.6 M
	2021	259 K
	2020	240 K

Other Fundumenentals of Repare Therapeutics

Net Interest Income

Repare Therapeutics Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Short Term Investments
Total Assets		1.0	0.91	-0.88	-0.69	0.4	0.57	0.82	0.74	0.98	1.0	0.89	0.99	0.89	0.83	0.65	0.74	0.61
Total Stockholder Equity	1.0		0.92	-0.87	-0.73	0.47	0.63	0.84	0.67	0.97	1.0	0.91	0.99	0.91	0.87	0.63	0.76	0.62
Net Tangible Assets	0.91	0.92		-0.73	-0.86	0.64	0.8	0.89	0.55	0.96	0.91	0.99	0.89	0.99	0.95	0.58	0.86	0.66
Net Debt	-0.88	-0.87	-0.73		0.38	-0.32	-0.31	-0.52	-0.72	-0.84	-0.88	-0.67	-0.91	-0.67	-0.59	-0.33	-0.41	-0.2
Retained Earnings	-0.69	-0.73	-0.86	0.38		-0.75	-0.9	-0.96	-0.21	-0.74	-0.69	-0.91	-0.66	-0.91	-0.89	-0.53	-0.93	-0.72
Accounts Payable	0.4	0.47	0.64	-0.32	-0.75		0.82	0.64	-0.21	0.44	0.4	0.66	0.42	0.66	0.68	-0.06	0.55	0.17
Net Receivables	0.57	0.63	0.8	-0.31	-0.9	0.82		0.8	-0.01	0.63	0.57	0.83	0.56	0.83	0.89	0.29	0.83	0.61
Capital Surpluse	0.82	0.84	0.89	-0.52	-0.96	0.64	0.8		0.41	0.83	0.82	0.94	0.78	0.94	0.88	0.65	0.95	0.76
Total Liab	0.74	0.67	0.55	-0.72	-0.21	-0.21	-0.01	0.41		0.75	0.74	0.51	0.73	0.51	0.36	0.63	0.37	0.4
Net Invested Capital	0.98	0.97	0.96	-0.84	-0.74	0.44	0.63	0.83	0.75		0.98	0.94	0.97	0.94	0.86	0.64	0.78	0.63
Total Current Assets	1.0	1.0	0.91	-0.88	-0.69	0.4	0.57	0.82	0.74	0.98		0.89	0.99	0.89	0.84	0.65	0.74	0.62
Capital Stock	0.89	0.91	0.99	-0.67	-0.91	0.66	0.83	0.94	0.51	0.94	0.89		0.87	1.0	0.96	0.61	0.91	0.71
Net Working Capital	0.99	0.99	0.89	-0.91	-0.66	0.42	0.56	0.78	0.73	0.97	0.99	0.87		0.87	0.82	0.58	0.69	0.54
Common Stock	0.89	0.91	0.99	-0.67	-0.91	0.66	0.83	0.94	0.51	0.94	0.89	1.0	0.87		0.96	0.61	0.91	0.71
Property Plant Equipment	0.83	0.87	0.95	-0.59	-0.89	0.68	0.89	0.88	0.36	0.86	0.84	0.96	0.82	0.96		0.6	0.87	0.75
Current Deferred Revenue	0.65	0.63	0.58	-0.33	-0.53	-0.06	0.29	0.65	0.63	0.64	0.65	0.61	0.58	0.61	0.6		0.7	0.89
Short Term Debt	0.74	0.76	0.86	-0.41	-0.93	0.55	0.83	0.95	0.37	0.78	0.74	0.91	0.69	0.91	0.87	0.7		0.85
Short Term Investments	0.61	0.62	0.66	-0.2	-0.72	0.17	0.61	0.76	0.4	0.63	0.62	0.71	0.54	0.71	0.75	0.89	0.85

Click cells to compare fundamentals

About Repare Therapeutics Financial Statements

Repare Therapeutics investors use historical fundamental indicators, such as Repare Therapeutics' Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Repare Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	11.9 M	12.5 M
Net Interest Income	11.9 M	6.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Repare Stock Analysis

When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Repare Interest Income from 2010 to 2026

Latest Repare Therapeutics' Interest Income Growth Pattern

Repare Interest Income Regression Statistics

Repare Interest Income History

Other Fundumenentals of Repare Therapeutics

Repare Therapeutics Interest Income component correlations

About Repare Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Repare Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY